Abstract:
The brain noradrenergic system plays a pivotal role in mediating the responses of the organism to the external and internal milieu and particularly to stress. The different components of this system have been implicated in a wide range of normal and pathological behavior. Recent advances in molecular psychiatric genetics may pave the way for a better understanding of the etiology of different symptoms of mental diseases and their relationship to environmental factors.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- AAD:
-
Aromatic Amino acid Decarboxylase
- AC:
-
adenylyl cyclase
- ADs:
-
antidepressant drugs
- BMP:
-
Bone Morphogenetic Proteins
- COMT:
-
catechol-O-methyltransferase
- DAG:
-
diacylglycerol
- DOPA:
-
3,4 dihydroxyphenylalanine
- DHPG:
-
3,4-dihydroxyphenyl-glycol
- MHPG:
-
3-methoxy-4-hydroxyphenylglycol
- fmri:
-
functional magnetic resonance imaging
- Gata3:
-
GATA-binding protein 3
- GDP:
-
guanosine diphosphate
- GPCRs:
-
G protein-coupled receptors
- GTP:
-
guanosine triphosphate
- HPA:
-
hypothalamic-pituitary-adrenal
- LC:
-
Locus Coeruleus
- MAOs:
-
monoamineoxidases
- NET:
-
NE transporter
- PKC:
-
protein kinase C
- PKA:
-
protein kinases A
- PNMT:
-
Phenylethanolamine-N-Methyl-Transferase
- PLC:
-
phospholipase C
- PTSD:
-
posttraumatic stress disorder
- SSRIs:
-
selective serotonin reuptake inhibitors
- TH:
-
Tyrosine Hydroxylase
- VMA:
-
vanyl-mandelic acid
- VCF:
-
velocardiofacial syndrome
- VMAT:
-
vesicular monoamine transporter
References
Albanese V, Biguet NF, Kiefer H, Bayard E, Mallet, J, et al. 2001. Quantitative effects on gene silencing by allelic variation at a tetranucleotide microsatellite. Hum Mol Genet 10: 1785–1792.
Archer T. 1982. The role of noradrenaline in learned behaviors: Studies using DSP4. Scand J Psychol Suppl 1: 61–71.
Aston-Jones G, Cohen, JD. 2005. An integrative theory of locus coeruleus-norepinephrine function: Adaptive gain and optimal performance. Annu Rev Neurosci 28: 403–450.
Aston-Jones G, Rajkowski J, Cohen J. 1999. Role of locus coeruleus in attention and behavioral flexibility. Biol Psychiatry 46: 1309–1320.
Aston-Jones G, Rajkowski J, Kubiak P, Alexinsky T. 1994. Locus coeruleus neurons in monkey are selectively activated by attended cues in a vigilance task. J Neurosci 14: 4467–4480.
Beaulieu J-M, Sotnikova TD, Yao W.-D, Kockeritz L, Woodgett JR, et al. 2004. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proc Natl Acad Sci USA 101: 5099–5104.
Benjamin J, Osher Y, Kotler M, Gritsenko I, Nemanov L, et al. 2000. Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: Dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol-O-methyltransferase (COMT). Mol Psychiatry 5: 96–100.
Berridge M. 1993. Cell signalling. A tale of two messengers. Nature 365: 388–389.
Berridge CW, Waterhouse BD. 2003. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res Rev 42: 33–84.
Bertocci B, Miggiano V, Da Prada M, Dembic Z, Lahm, HW, et al. 1991. Human catechol-O-methyltransferase: Cloning and expression of the membrane-associated form. Proc Natl Acad Sci USA 88: 1416–1420.
Boehm S, Kubista, H. 2002. Fine tuning of sympathetic transmitter release via ionotropic and metabotropic presynaptic receptors. Pharmacol Rev 54: 43–99.
Bray N, Buckland P, Williams N, Williams H, Norton N, et al. 2003. A haplotype implicated in schizophrenia susceptibility is associated with reduced COMT expression in human brain. Am J Hum Genet 73: 152–161.
Brinkmann B, Sajantila A, Goedde H, Matsumoto H, Nishi K, et al. 1996. Population genetic comparisons among eight populations using allele frequency and sequence data from three microsatellite loci. Eur J Hum Genet 4: 175–182.
Brunet J-F, Pattyn A. 2002. Phox2 genes—from patterning to connectivity. Curr Opin Genet Dev 12: 435–440.
Brunner HG, Nelen M, Breakfield XO, Ropers HH, Van Oost B. 1993. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science 262: 578–580.
Burgert E, Crocq MA, Bausch E, Macher JP, Morris-Rosendahl DJ. 1998. No association between the tyrosine hydroxylase microsatellite marker HUMTH01 and schizophrenia or bipolar I disorder. Psychiatr Genet 8: 45–48.
Byerley W, Plaetke R, Hoff M, Jensen S, Holik J, et al. 1992. Tyrosine hydroxylase gene not linked to manic-depression in seven of eight pedigrees. Hum Hered 42: 259–263.
Bylund D. 1992. Subtypes of alpha 1- and alpha 2-adrenergic receptors. FASEB J 6: 832–839.
Bylund, DB. 2005. Alpha-2 adrenoceptor subtypes: Are more better? 144: 159-160.
Bylund D, Eikenberg D, Hieble J, Langer S, Lefkowitz R, et al. 1994. International union of pharmacology nomenclature of adrenoceptors. Pharmacol Rev 46: 121–136.
Cases O, Self I, Grimsby J, Gaspar P, Chen K, et al. 1995. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science 268: 1763–1766.
Caspi A, McClay J, Moffitt TE, Mill J, Martin J, et al. 2002. Role of genotype in the cycle of violence in maltreated children. Science 297: 851–854.
Cavazzoni P, Alda M, Turecki G, Rouleau G, Grof E, et al. 1996. Lithium-responsive affective disorders: No association with the tyrosine hydroxylase gene. Psychiatry Res 64: 91–96.
de Chaldee M, Laurent C, Thibaut F, Martinez M, Samolyk D, et al. 1999. Linkage disequilibrium on the COMT gene in French schizophrenics and controls. Am J Med Genet 88: 452–457.
Chen CH, Lee YR, Wei FC, Koong FJ, Hwu HG, et al. 1997. Association study of NlaIII and MspI genetic polymorphisms of catechol-O-methyltransferase gene and susceptibility to schizophrenia. Biol Psychiatry 41: 985–987.
Chiba M, Suzuki S, Hinokio Y, Hirai M, Satoh Y, et al. 2000. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 49: 1145–1149.
Craddock N, Spurlock G, McGuffin P, Owen MJ, Nosten- Bertrand M, et al. 1997. No association between bipolar disorder and alleles at a functional polymorphism in the COMT gene. Br J Psychiatry 170: 526–528.
Craig SP, Buckle VJ, Lamouroux A, Mallet J, Craig IW. 1988. Localization of the human dopamine beta hydroxylase (DBH) gene to chromosome 9q34. Cytogenet Cell Genet 48: 48–50.
Croager EJ, Gout AM, Abraham LJ. 2000. Involvement of Sp1 and microsatellite repressor sequences in the transcriptional control of the human CD30 gene. Am J Pathol 156: 1723–1731.
Cubells JF, van Kammen DP, Kelley ME, Anderson GM, O'Connor DT, et al. 1998. Dopamine beta-hydroxylase: Two polymorphisms in linkage disequilibrium at the structural gene DBH associate with biochemical phenotypic variation. Hum Genet 102: 533–540.
Cubells JF, Kobayashi K, Nagatsu T, Kidd KK, Kidd JR, et al. 1997. Population genetics of a functional variant of the dopamine beta-hydroxylase gene (DBH). Am J Med Genet 74: 374–379.
Cubells JF, Kranzler HR, McCance-Katz E, Anderson GM, Malison RT, et al. 2000. A haplotype at the DBH locus, associated with low plasma dopamine beta-hydroxylase activity, also associates with cocaine-induced paranoia. Mol Psychiatry 5: 56–63.
Daly G, Hawi Z, Fitzgerald M, Gill M. 1999. Mapping susceptibility loci in attention deficit hyperactivity disorder: Preferential transmission of parental alleles at DAT1, DBH and DRD5 to affected children. Mol Psychiatry 4: 192–196.
Daniels JK, Williams NM, Williams J, Jones LA, Cardno AG, et al. 1996. No evidence for allelic association between schizophrenia and a polymorphism determining high or low catechol-O-methyltransferase activity. Am J Psychiatry 153: 268–270.
De Benedictis G, Carotenuto L, Carrieri G, De Luca M, Falcone E, et al. 1998. Gene/longevity association studies at four autosomal loci (REN, THO, PARP, SOD2). Eur J Hum Genet 6: 534–541.
Deckert J, Catalano M, Syagailo Y, Bosi M, Okladnova O, et al. 1999. Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8: 621–624.
Deinum J, Steenbergen-Spanjers GCH, Jansen M, Boomsma F, Lenders JWM, et al. 2004. DBH gene variants that cause low plasma dopamine {beta} hydroxylase with or without a severe orthostatic syndrome. J Med Genet 41: e38.
Detera-Wadleigh S, Berrettini W, Goldin L, Boorman D, Anderson S, et al. 1987. Close linkage of c-Harvey-ras-1 and the insulin gene to affective disorder is ruled out in three North American pedigrees. Nature 325: 806–808.
Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, et al. 2001. Effect of COMT val108/158 met genotype on frontal lobe function and risk for schizophrenia. Proc Natl Acad Sci USA 98: 6917–6922.
Egeland JA, Gerhard DS, Pauls DL, Sussex JN, Kidd KK, et al. 1987. Bipolar affective disorders linked to DNA markers on chromosome 11. Nature 325: 783–787.
Eisenhofer G, Kopin IJ, Goldstein DS. 2004. Catecholamine metabolism: A contemporary view with implications for physiology and medicine. Pharmacol Rev 56: 331–349.
Fan J-B, Yang M-S, Tang J-X, He L, Xing YL, et al. 2004. Family-based association study of the functional monoamine oxidase a gene promoter polymorphism and schizophrenia. Schizophr Res 67: 107–109.
Ferguson SSG. 2001. Evolving concepts in G protein-coupled receptor endocytosis: The role in receptor desensitization and signaling. Pharmacol Rev 53: 1–24.
Ferguson J, Wesnes K, Schwartz G. 2003. Reboxetine versus paroxetine versus placebo: Effects on cognitive functioning in depressed patients. Int Clin Psychopharmacol 18: 9–14.
Fields TA, Casey PJ. 1997. Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins. Biochem J 321: 561–571.
Foley DL, Eaves LJ, Wormley B, Silberg JL, Maes HH, et al. 2004. Childhood adversity, monoamine oxidase a genotype, and risk for conduct disorder. Arch Gen Psychiatry 61: 738–744.
Fuller R, Hemrick-Luecke S, Littlefield E, Audia J. 1995. Comparison of desmethylsertraline with sertraline as a monoamine uptake inhibitor in vivo. Prog Neuropsychopharmacol Biol Psychiatry 19: 135–149.
Furlong RA, Rubinsztein JS, Ho L, Walsh C, Coleman TA, et al. 1999. Analysis and metaanalysis of two polymorphisms within the tyrosine hydroxylase gene in bipolar and unipolar affective disorders. Am J Med Genet 88: 88–94.
Gallinat J, Bajbouj M, Sander T, Schlattmann P, Xu K, et al. 2003. Association of the G1947A COMT (Val108/158Met) gene polymorphism with prefrontal P300 during information processing. Biol Psychiatry 54: 40–48.
Garland EM, Hahn MK, Ketch TP, Keller NR, Kim CH, et al. 2002. Genetic Basis of clinical catecholamine disorders. Ann NY Acad Sci 971: 506–514.
Geller B, Cook Jr., EH. 2000. Ultradian rapid cycling in prepubertal and early adolescent bipolarity is not in transmission disequilibrium with val/met COMT alleles. Biol Psychiatry 47: 605–609.
Gerhard D, LaBuda M, Bland S, Allen C, Egeland J, et al. 1994. Initial report of a genome search for the affective disorder predisposition gene in the old order amish pedigrees: Chromosomes 1 and 11. Am J Med Genet 54: 398–404.
Gershon E, Goldin L, Badner J, Berrettini W. 1996. Detection of linkage to affective disorders in the catalogued amish pedigrees: A reply to Pauls et al. Am J Hum Genet 58: 1381–1385.
Gether U. 2000. Uncovering molecular mechanisms involved in activation of G protein-coupled receptors. Endocr Rev 21: 90–113.
Gill M, Castle D, Hunt N, Clements A, Sham P, et al. 1991. Tyrosine hydroxylase polymorphisms and bipolar affective disorder. J Psychiatr Res 25: 179–184.
Ginns E, Egeland J, Allen C, Pauls D, Falls K, et al. 1992. Update on the search for DNA markers linked to manic-depressive illness in the old order amish. J Psychiatr Res 26: 305–308.
Ginns E, Ott J, Egeland J, Allen C, Fann C, et al. 1996. A genome-wide search for chromosomal loci linked to bipolar affective disorder in the old order amish. Nat Genet 12: 431–435.
Goridis C, Rohrer H. 2002. Specification of catecholaminergic and serotonergic neurons. Nat Rev Neurosci 3: 531–541.
Grace AA. 1991. Phasic versus tonic dopamine release and the modulation of dopamine system responsivity: A hypothesis for the etiology of schizophrenia. Neuroscience 41: 1–24.
Grace AA. 1993. Cortical regulation of subcortical dopamine systems and its possible relevance to schizophrenia. J Neural Transm Gen Sect 91: 111–134.
Grossman MH, Emanuel BS, Budarf ML. 1992. Chromosomal mapping of the human catechol-O-methyltransferase gene to 22q11.1–q11.2. Genomics 12: 822–825.
Gurling H, Smyth C, Kalsi G, Moloney E, Rifkin L, et al. 1995. Linkage findings in bipolar disorder. Nat Genet 10: 8–9.
Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, et al. 1997. Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry 154: 113–115.
HamiltonS, Slager S, Heiman G, Haghighi F, Klein D, et al. 2000. No genetic linkage or association between a functional promoter polymorphism in the monoamine oxidase-A gene and panic disorder. Mol Psychiatry 5: 465–466.
Hawi Z, Lowe N, Kirley A, Gruenhage F, Nothen M, et al. 2003. Linkage disequilibrium mapping at DAT1, DRD5 and DBH narrows the search for ADHD susceptibility alleles at these loci. Mol Psychiatry 8: 299–308.
Hoda F, Nicholl D, Bennett P, Arranz M, Aitchison KJ, et al. 1996. No association between Parkinson's disease and low-activity alleles of catechol-O-methyltransferase. Biochem Biophys Res Commun 228: 780–784.
Hodgkinson S, Sherrington R, Gurling H, Marchbanks R, Reeders S, et al. 1987. Molecular genetic evidence for heterogeneity in manic depression. Nature 325: 805–806.
Houhou L, Lamouroux A, Faucon Biguet N, Mallet J. 1995. Expression of human dopamine β-hydroxylase in mammalian cells infected by recombinant vaccinia virus. J Biol Chem 270: 12601–12606.
Huang Y, Cate S, Battistuzzi C, Oquendo M, Brent D, et al. 2004. An association between a functional polymorphism in the monoamine oxidase a gene promoter, impulsive traits and early abuse experiences. Neuropsychopharmacology 29: 1498–1505.
Hubbard KB, Hepler JR. 2006. Cell signalling diversity of the Gq[alpha] family of heterotrimeric G proteins. Cellular Signalling 18: 135–150.
Ibanez A, Perez de Castro I, Fernandez-Piqueras J, Blanco C, Saiz-Ruiz J. 2000. Pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. Mol Psychiatry 5: 105–109.
Icard Liepkalns C, Faucon Biguet N, Vyas S, Robert JJ, Sassone Corsi P, et al. 1992. AP-1 complex and c-fos transcription are involved in TPA provoked and trans-synaptic inductions of the tyrosine hydroxylase gene: Insights into long-term regulatory mechanisms. J Neurosci Res 32: 290–298.
Inayama Y, Yoneda H, Sakai T, Ishida T, Kobayashi S, et al. 1993. Lack of association between bipolar affective disorder and tyrosine hydroxylase DNA marker. Am J Med Genet 48: 87–89.
Ishii A, Kobayashi K, Kiuchi K, Nagatsu T. 1991. Expression of two forms of human dopamine-beta-hydroxylase in COS cells. Neurosci Lett 125: 25–28.
Jindra A, Jachymova M, Horky K, Peleska J, Umnerova V, et al. 2000. Association analysis of two tyrosine hydroxylase gene polymorphisms in normotensive offspring from hypertensive families. Blood Press 9: 250–254.
Jönsson EG, Bah J, Melke J, Jamra RA, Schumacher J, et al. 2004. Monoamine related functional gene variants and relationships to monoamine metabolite concentrations in CSF of healthy volunteers. BMC Psychiatry 4: 4.
Jonsson EG, Geijer T, Gyllander A, Terenius L, Sedvall GC. 1998. Failure to replicate an association between a rare allele of a tyrosine hydroxylase gene microsatellite and schizophrenia. Eur Arch Psychiatry Clin Neurosci 248: 61–63.
Jonsson EG, Norton N, Forslund K, Mattila-Evenden M, Rylander G, et al. 2003. Association between a promoter variant in the monoamine oxidase A gene and schizophrenia. Schizophr Res 61: 31–37.
Jonsson E, Sedvall G, Brene S, Gustavsson JP, Geijer T, et al. 1996. Dopamine-related genes and their relationships to monoamine metabolites in CSF. Biol Psychiatry 40: 1032–1043.
Jorm A, Henderson A, Jacomb P, Christensen H, Korten A, et al. 2000. Association of a functional polymorphism of the monoamine oxidase A gene promoter with personality and psychiatric symptoms. Psychiatr Genet 10: 87–90.
Kang J, Shi Y, Xiang B, Qu B, Su W, et al. 2005. A nuclear function of [beta]-arrestin1 in GPCR signaling: Regulation of histone acetylation and gene transcription. Cell 123: 833–847.
Karayiorgou M, Altemus M, Galke BL, Goldman D, Murphy DL, et al. 1997. Genotype determining low catechol-O-methyltransferase activity as a risk factor for obsessive-compulsive disorder. Proc Natl Acad Sci USA 94: 4572–4575.
Karayiorgou M, Gogos J. 1997. A turning point in schizophrenia genetics. Neuron 19: 967–979.
Karayiorgou M, Gogos JA, Galke BL, Wolyniec PS, Nestadt G, et al. 1998. Identification of sequence variants and analysis of the role of the catechol-O-methyl-transferase gene in schizophrenia susceptibility. Biolo Psychiatry 43: 425–431.
Karayiorgou M, Morris MA, Morrow B, Shprintzen RJ, Goldberg R, et al. 1995. Schizophrenia susceptibility associated with interstitial deletions of chromosome 22q11. Proc Natl Acad Sci USA 92: 7612–7616.
Kawada Y, Hattori M, Fukuda R, Arai H, Inoue R, et al. 1995. No evidence of linkage or association between tyrosine hydroxylase gene and affective disorder. J Affect Disord 34: 89–94.
Kelsoe J, Ginns E, Egeland J, Gerhard D, Goldstein A, et al. 1989. Re-evaluation of the linkage relationship between chromosome 11p loci and the gene for bipolar affective disorder in the old order amish. Nature 342: 238–243.
Kirov G, Norton N, Jones I, McCandless F, Craddock N, et al. 1999. A functional polymorphism in the promoter of monoamine oxidase A gene and bipolar affective disorder. Int J Neuropsychopharmcol 2: 293–298.
Klimek V, Stockmeier C, Overholser J, Meltzer HY, Kalka S, et al. 1997. Reduced levels of norepinephrine transporters in the locus coeruleus in major depression. J Neurosci 17: 8451–8458.
Kohnke MD, Zabetian CP, Anderson GM, Kolb W, Gaertner I, et al. 2002. A genotype-controlled analysis of plasma dopamine [beta]-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function. Biol Psychiatry 52: 1151–1158.
Korner J, Fritze J, Propping P. 1990. RFLP alleles at the tyrosine hydroxylase locus: No association found to affective disorders. Psychiatry Res 32: 275–280.
Korner J, Rietschel M, Hunt N, Castle D, Gill M, et al. 1994. Association and haplotype analysis at the tyrosine hydroxylase locus in a combined German–British sample of manic depressive patients and controls. Psychiatr Genet 4: 167–175.
Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, et al. 1999. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 4: 393–395.
Kunugi H, Nanko S, Ueki A, Otsuka E, Hattori M, et al. 1997a. High and low activity alleles of catechol-O-methyltransferase gene: Ethnic difference and possible association with Parkinson's disease. Neurosci Lett 221: 202–204.
Kunugi H, Vallada HP, Hoda F, Kirov G, Gill M, et al. 1997b. No evidence for an association of affective disorders with high- or low-activity allele of catechol-O-methyltransferase gene. Biol Psychiatry 42: 282–285.
Kurumaji A, Kuroda T, Yamada K, Yoshikawa T, Toru M. 2001. An association of the polymorphic repeat of tetranucleotide (TCAT) in the first intron of the human tyrosine hydroxylase gene with schizophrenia in a Japanese sample. J Neural Transm 108: 489–495.
Lachman HM, Kelsoe J, Moreno L, Katz S, Papolos DF. 1997. Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder. Psychiatric Genet 7: 13–17.
Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, et al. 1996b. Association of codon 108/158 catechol-O-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67: 468–472.
Lachman HM, Nolan KA, Mohr P, Saito T, Volavka J. 1998. Association between catechol-O-methyltransferase genotype and violence in schizophrenia and schizoaffective disorder. Am J Psychiatry 155: 835–837.
Lachman HM, Papolos DF, Saito T, Yu Y-M, Szumlanski CL, et al. 1996a. Human catechol-O-methyltransferase pharmacogenetics: Description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6: 243–250.
Lan NC, Heinzmann C, Gal A, Klisak I, Orth U, et al. 1989. Human monoamine oxidase A and B genes map to Xp 11.23 and are deleted in a patient with norrie disease. Genomics 4: 552–559.
Leboyer M, Malafosse A, Boularand S, Campion D, Gheysen F, et al. 1990. Tyrosine hydroxylase polymorphisms associated with manic-depressive illness. Lancet 335: 1219.
Leonard B. 2001. Stress, norepinephrine and depression. J Psychiatry Neurosci 26: Suppl: S11–S16.
Lester HA, Cao Y, Mager S. 1996. Listening to neurotransmitter transporters. Neuron 17: 807–810.
Li T, Vallada H, Curtis D, Arranz M, Xu K, et al. 1997. Catechol-O-methyltransferase Val158Met polymorphism: Frequency analysis in Han Chinese subjects and allelic association of the low activity allele with bipolar affective disorder. Pharmacogenetics 7: 349–353.
Lim LC, Gurling H, Curtis D, Brynjolfsson J, Petursson H, et al. 1993. Linkage between tyrosine hydroxylase gene and affective disorder cannot be excluded in two of six pedigrees. Am J Med Genet 48: 223–228.
Lobos EA, Todd RD. 1997. Cladistic analysis of disease association with tyrosine hydroxylase: Application to manic-depressive disease and alcoholism. Am J Med Genet 74: 289–295.
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. 2003. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nat Genet 33: 177–182.
Lotta T, Vidgren J, Tilgmann C, Ulmanen I, Melen K, et al. 1995. Kinetics of human soluble and membrane-bound catechol-O-methyltransferase: A revised mechanism and description of the thermolabile variant of the enzyme. Biochemistry 34: 4202–4210.
Lundstrom K, Tenhunen J, Tilgmann C, Karhunen T, Panula P, et al. 1995. Cloning, expression and structure of catechol-O-methyltransferase. Biochim Biophys Acta Protein Structure and Molecular Enzymology 1251: 1–10.
Malafosse A, Leboyer M, d'Amato T, Amadeo S, Abbar M, et al. 1997. Manic depressive illness and tyrosine hydroxylase gene: Linkage heterogeneity and association. Neurobiol Dis 4: 337–349.
Mallet J. 1996. The TiPS/TINS lecture. Catecholamines: From gene regulation to neuropsychiatric disorders. Trends Pharmacol Sci 17: 129–135.
Mandela P, Ordway GA. 2006. The norepinephrine transporter and its regulation. J Neurochem 97: 310–333.
Masson J, Sagne C, Hamon M, Mestikawy SE. 1999. Neurotransmitter transporters in the central nervous system. Pharmacol Rev 51: 439–464.
Mattay VS, Goldberg TE., Fera F, Hariri AR., Tessitore A, et al. 2003. Catechol-O-methyltransferase val158-met genotype and individual variation in the brain response to amphetamine. Proc Natl Acad Sci USA 100: 6186–6191.
Melia K, Duman R. 1991. Involvement of corticotropin-releasing factor in chronic stress regulation of the brain noradrenergic system. Proc Natl Acad Sci USA 88: 8382–8386.
Melia K, Rasmussen K, Terwilliger R, Haycock J, Nestler E, et al. 1992. Coordinate regulation of the cyclic AMP system with firing rate and expression of tyrosine hydroxylase in the rat locus coeruleus: Effects of chronic stress and drug treatments. J Neurochem 58: 494–502.
Meloni R, Albanese V, Ravassard P, Treilhou F, Mallet J. 1998. A tetranucleotide polymorphic microsatellite, located in the first intron of the tyrosine hydroxylase gene, acts as a transcription regulatory element in vitro. Hum Mol Genet 7: 423–428.
Meloni R, Laurent C, Campion D, Ben Hadjali B, Thibaut F, et al. 1995b. A rare allele of a microsatellite located in the tyrosine hydroxylase gene found in schizophrenic patients. C R Acad Sci III 318: 803–809.
Meloni R, Leboyer M, Bellivier F, Barbe B, Samolyk D, et al. 1995a. Association of manic-depressive illness with tyrosine hydroxylase microsatellite marker. Lancet 345: 932.
Meyer E, Wiegand P, Rand SP, Kuhlmann D, Brack M, et al. 1995. Microsatellite polymorphisms reveal phylogenetic relationships in primates. J Mol Evol 41: 10–14.
Moore H, West AR, Grace AA. 1999. The regulation of forebrain dopamine transmission: Relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 46: 40–55.
Morilak DA, Barrera G, Echevarria DJ, Garcia AS, Hernandez A, et al. 2005. Role of brain norepinephrine in the behavioral response to stress. Prog Neuropsychopharmacol Biol Psychiatry—Experimental Stress: From Basic to Clinical Aspects 29: 1214–1224.
Müller Smith K, Daly M, Fischer M, Yiannoutsos CT, Bauer L, et al. 2003. Association of the dopamine beta hydroxylase gene with attention deficit hyperactivity disorder: Genetic analysis of the Milwaukee longitudinal study. Am J Med Genet 119B: 77–85.
Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P. 1998. Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 8: 221–225.
Neer EJ. 1995. Heterotrimeric C proteins: Organizers of transmembrane signals. Cell 80: 249–257.
Nelson JC. 1999. A review of the efficacy of serotonergic and noradrenergic reuptake inhibitors for treatment of major depression. Biol Psychiatry 46: 1301–1308.
Njus D, Kelley P, Harnadek G. 1986. Bioenergetics of secretory vesicles. Biochim Biophys Acta 853: 237–265.
Ohmori O, Shinkai T, Kojima H, Terao T, Suzuki T, et al. 1998. Association study of a functional catechol-O-methyltransferase gene polymorphism in Japanese schizophrenics. Neurosci Lett 243: 109–112.
Ordway G. 1997. Pathophysiology of the locus coeruleus in suicide. Ann N Y Acad Sci 836: 233–252.
Pakstis A, Kidd J, Castiglione C, Kidd K. 1991. Status of the search for a major genetic locus for affective disorder in the old order amish. Hum Genet 87: 475–483.
Palmatier MA, Kang AM, Kidd KK. 1999. Global variation in the frequencies of functionally different catechol-O-methyltransferase alleles. Biol Psychiatry 46: 557–567.
Perez de Castro I, Santos J, Torres P, Visedo G, Saiz-Ruiz J, et al. 1995. A weak association between TH and DRD2 genes and bipolar affective disorder in a Spanish sample. J Med Genet 32: 131–134.
Persson ML, Wasserman D, Jonsson EG, Bergman H, Terenius L, et al. 2000. Search for the influence of the tyrosine hydroxylase (TCAT)(n) repeat polymorphism on personality traits. Psychiatry Res 95: 1–8.
Polymeropoulos M, Xiao H, Rath D, Merril C. 1991. Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 19: 3753.
de Pontual L, Nepote V, Attie-Bitach T, Al Halabiah H, Trang H, et al. 2003. Noradrenergic neuronal development is impaired by mutation of the proneural HASH-1 gene in congenital central hypoventilation syndrome (ondine's curse). Hum Mol Genet 12: 3173–3180.
Puers C, Hammond HA, Jin L, Caskey T, Schumm JW. 1993. Identification of repeat sequence heterogeneity at the polymorphic short tandem repeat locus HUMTH01 (AATG)n and reassignment of alleles in population analysis by using a locus-specific allelic ladder. Am J Hum Genet 53: 953–958.
Pulver AE, Karayiorgou M, Lasseter VK, Wolyniec P, Kasch L, et al. 1994b. Follow-up of a report of a potential linkage for schizophrenia on chromosome 22q12–q13.1: Part 2. Am J Med Genet 54: 44–50.
Pulver AE, Karayiorgou M, Wolyniec PS, Lasseter VK, Kasch L, et al. 1994a. Sequential strategy to identify a susceptibility gene for schizophrenia: Report of potential linkage on chromosome 22q12–q13.1: Part 1. Am J Med Genet 54: 36–43.
Sabban EL, Kvetnansky R. 2001. Stress-triggered activation of gene expression in catecholaminergic systems: Dynamics of transcriptional events. Trends Neurosci 24: 91–98.
Sabol S, Hu S, Hamer D. 1998. A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103: 273–279.
Sander T, Harms H, Rommelspacher H, Hoehe M, Schmidt LG. 1998. Possible allelic association of a tyrosine hydroxylase polymorphism with vulnerability to alcohol-withdrawal delirium. Psychiatr Genet 8: 13–17.
Sassone-Corsi P, Lamph WW, Kamps M, Verma IM. 1988. Fos-associated cellular p39 is related to nuclear transcription factor AP-1. Cell 54: 553–560.
Schatzberg A. 2000. Clinical efficacy of reboxetine in major depression. J Clin Psychiatry 61: 31–38.
Schildkraut JJ. 1965. The catecholamine hypothesis of affective disorders: A review of supporting evidence. Am J Psychiatry 122: 509–522.
Schultz, W, Dayan P, Montague P. 1997. A neural substrate of prediction and reward. Science 275: 1593–1599.
Schulze T, Muller D, Krauss H, Scherk H, Ohlraun S, et al. 2000. Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96: 801–803.
SerrettiA, Macciardi F, Cusin C, Verga M, Pedrini S, 1998a. Tyrosine hydroxylase gene in linkage disequilibrium with mood disorders. Mol Psychiatry 3: 169–174.
Serretti A, Macciardi F, Verga M, Cusin C, Pedrini S, et al. 1998b. Tyrosine hydroxylase gene associated with depressive symptomatology in mood disorder. Am J Med Genet 81: 127–130.
Servan-Schreiber D, Printz H, Cohen J. 1990. A network model of catecholamine effects: Gain, signal-to-noise ratio, and behavior. Science 249: 892–895.
Shifman S, Bronstein M, Sternfeld M, Pisanté A, Weizman A, et al. 2004. COMT: A common susceptibility gene in bipolar disorder and schizophrenia. Am J Med Genet 128B: 61–64.
Shifman S, Bronstein M, Sternfeld M, Pisante-Shalom A, Lev-Lehman E, et al. 2003. A highly significant association between a COMT haplotype and schizophrenia. Am J Hum Genet 71: 1296–1302.
Shih JC, Chen K, Ridd, J. 1999. Monoamine oxidase: From genes to behavior. Annu Rev Neurosci 22: 197–217.
Smyth C, Kalsi G, Brynjolfsson J, O'Neill J, Curtis D, et al. 1996. Further tests for linkage of bipolar affective disorder to the tyrosine hydroxylase gene locus on chromosome 11p15 in a new series of multiplex British affective disorder pedigrees. Am J Psychiatry 153: 271–274.
Souery D, Lipp O, Mahieu B, Mendelbaum K, De Martelaer V, et al. 1996. Association study of bipolar disorder with candidate genes involved in catecholamine neurotransmission: DRD2, DRD3, DAT1, and TH genes. Am J Med Genet 67: 551–555.
Souery D, Lipp O, Rivelli SK, Massat I, Serretti A, et al. 1999. Tyrosine hydroxylase polymorphism and phenotypic heterogeneity in bipolar affective disorder: A multicenter association study. Am J Med Genet 88: 527–532.
Southwick S, Yehuda R, Giller EJ. 1993. Personality disorders in treatment-seeking combat veterans with posttraumatic stress disorder. Am J Psychiatry 150: 1020–1023.
Starke K. 2001. Presynaptic autoreceptors in the third decade: Focus on alpha2-adrenoceptors. J Neurochem 78: 685–693.
Stolk JM, Hurst JH, Nisula BC. 1982. Regulation and inheritance of dopamine-beta-hydroxylase. Behav Genet 12: 37–52.
Strous RD, Bark N, Woerner M, Lachman HM. 1997. Lack of association of a functional catechol-O-methyltransferase gene polymorphism in schizophrenia. Biol Psychiatry 41: 493–495.
Sugama S, Namihira T, Matsuoka R, Taira N, Eto Y, et al. 1999. Psychiatric inpatients and chromosome deletions within 22q11.2. J Neurol Neurosurg Psychiatry 67: 803–806.
Sullivan G, Coplan J, Kent J, Gorman J. 1999. The noradrenergic system in pathological anxiety: A focus on panic with relevance to generalized anxiety and phobias. Biol Psychiatry 46: 1205–1218.
Syagailo Y, Stober G, Grassle M, Reimer E, Knapp M, et al. 2001. Association analysis of the functional monoamine oxidase a gene promoter polymorphism in psychiatric disorders. Am J Med Genet 105: 168–171.
Syvanen A-C, Tilgmann C, Rinne J, Ulmanen I. 1997. Genetic polymorphism of catechol-O-methyltransferase (COMT): Correlation of genotype with individual variation of S-COMT activity and comparison of the allele frequencies in the normal population and Parkinsonian patients in Finland. Pharmacogenetics 7: 65–71.
Taussig R, Gilman AG. 1995. Mammalian membrane-bound adenylyl cyclases. J Biol Chem 270: 1–4.
Tenhunen J, Salminen M, Lundstrom K, Savolainen R, Ulmanen I. 1994. Genomic organization of the human catechol-O-methyltransferase gene and its expression from two distinct promoters. Eur J Biochem 223: 1049–1059.
Thibaut F, Ribeyre JM, Dourmap N, Meloni R, Laurent C, et al. 1997. Association of DNA polymorphism in the first intron of the tyrosine hydroxylase gene with disturbances of the catecholaminergic system in schizophrenia. Schizophr Res 23: 259–264.
Turecki G, Rouleau GA, Mari J, Joober R, Morgan K. 1997. Lack of association between bipolar disorder and tyrosine hydroxylase: A meta-analysis. Am J Med Genet 74: 348–352.
Vandenbergh DJ, Rodriguez LA, Miller IT, Uhl GR, Lachman HM. 1997. High-activity catechol-O-methyltransferase allele is more prevalent in polysubstance abusers. Am J Med Genet—Neuropsychiatric Genetics 74: 439–442.
Versiani M, Cassano G, Perugi G, Benedetti A, Mastalli L, et al. 2002. Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder. J Clin Psychiatry 63: 31–37.
Wei J, Hemmings GP. 1999. Lack of evidence for association between the COMT locus and schizophrenia. Psychiatr Genet 9: 183–186.
Wei J, Ramchand CN, Hemmings GP. 1995. Association of polymorphic VNTR region in the first intron of the human TH gene with disturbances of the catecholamine pathway in schizophrenia. Psychiatr Genet 5: 83–88.
Wei J, Ramchand CN, Hemmings GP. 1997. Possible association of catecholamine turnover with the polymorphic (TCAT)n repeat in the first intron of the human tyrosine hydroxylase gene. Life Sci 61: 1341–1347.
Wei J, Ramchand CN, Hemmings G. 1998. TaqI polymorphic sites at the human dopamine beta-hydroxylase gene possibly associated with biochemical alterations of the catecholamine pathway in schizophrenia. Psychiatr Genet 8: 19–24.
Weinberger DR, Egan MF, Bertolino A, Callicott JH, Mattay VS, et al. 2001. Prefrontal neurons and the genetics of schizophrenia. Biol Psychiatry 50: 825–844.
Weinshilboum R. 1978. Human biochemical genetics of plasma dopamine-[beta]-hydroxylase and erythrocyte catechol-O-methyltransferase. Hum Genet 45: 101–112.
Wigg K, Zai G, Schachar R, Tannock R, Roberts W, et al. 2002. Attention deficit hyperactivity disorder and the gene for dopamine beta-hydroxylase. Am J Psychiatry 159: 1046–1048.
Woodward D, Moises H, Waterhouse B, Yeh H, Cheun J. 1991. Modulatory actions of norepinephrine on neural circuits. Adv Exp Med Biol 287: 193–208.
Xie T, Ho SL, Li LSW, Ma OCK. 1997. G/A1947 polymorphism in catechol-O-methyltransferase (COMT) gene in Parkinson's disease. Mov Disord 12: 426–427.
Yamamoto K, Cubells J, Gelernter J, Benkelfat C, Lalonde P, et al. 2003. Dopamine beta-hydroxylase (DBH) gene and schizophrenia phenotypic variability: A genetic association study. Am J Med Genet 117B: 33–38.
Yamamoto K, Hornykiewicz O. 2004. Proposal for a noradrenaline hypothesis of schizophrenia. Prog Neuropsychopharmacol Biol Psychiatry 28: 913–922.
Young LJ, Nilsen R, Waymire KG, Mac Gregor GR, Insel TR. 1999. Increased affiliative response to vasopressin in mice expressing the V1a receptor from a monogamous vole. Nature 400: 766–768.
Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, et al. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68: 515–522.
Zabetian CP, Buxbaum SG, Elston RC, Köhnke MD, Anderson GM, et al. 2003. The structure of linkage disequilibrium at the DBH locus strongly influences the magnitude of association between diallelic markers and plasma dopamine—hydroxylase activity. Am J Hum Genet 72: 1389–1400.
Zhang L, Rao F, Wessel J, Kennedy BP, Rana BK, et al. 2004. Functional allelic heterogeneity and pleiotropy of a repeat polymorphism in tyrosine hydroxylase: Prediction of catecholamines and response to stress in twins. Physiol Genomics 19: 277–291.
Zhu MY, Klimek V, Dilley GE, Haycock JW, Stockmeier C, et al. 1999. Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression. Biol Psychiatry 46: 1275–1286.
Zhuma T, Tyrrell R, Sekkali B, Skavdis G, Saveliev A, et al. 1999. Human HMG box transcription factor HBP1: A role in hCD2 LCR function. EMBO J 18: 6396–6406.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2008 Springer Science+Business Media, LLC
About this entry
Cite this entry
Meloni, R. (2008). Molecular Genetics of Brain Noradrenergic Neurotransmission. In: Lajtha, A., Vizi, E.S. (eds) Handbook of Neurochemistry and Molecular Neurobiology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-30382-6_6
Download citation
DOI: https://doi.org/10.1007/978-0-387-30382-6_6
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-30351-2
Online ISBN: 978-0-387-30382-6
eBook Packages: Biomedical and Life SciencesReference Module Biomedical and Life Sciences